2015
DOI: 10.1038/oncsis.2015.25
|View full text |Cite
|
Sign up to set email alerts
|

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression

Abstract: Recent advances have highlighted profound roles of FOXO transcription factors, especially FOXO1, in bone development and remodeling. The regulation of bone development by FOXOs seems to be stage-specific or context dependent. FOXOs promote maintenance and differentiation of early progenitors of the osteoblast lineage and repress proliferation of committed osteoblast precursors; FOXO1 is vital for osteocyte survival. Considering the versatile roles played by FOXOs in bone development and tumorigenesis, it is pl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
51
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(59 citation statements)
references
References 47 publications
6
51
0
Order By: Relevance
“…Evidence indicates that Wnt/β‐catenin signaling pathway involves in maintenance and development of many tissues and organs, including bone . In fact, most OS cases are found to show β‐catenin overexpression and elevated nuclear localization, which is correlated with lung metastasis . In view of the complex regulatory role of miR‐940, it is necessary to explore its regulatory role in different disease models.…”
Section: Introductionmentioning
confidence: 99%
“…Evidence indicates that Wnt/β‐catenin signaling pathway involves in maintenance and development of many tissues and organs, including bone . In fact, most OS cases are found to show β‐catenin overexpression and elevated nuclear localization, which is correlated with lung metastasis . In view of the complex regulatory role of miR‐940, it is necessary to explore its regulatory role in different disease models.…”
Section: Introductionmentioning
confidence: 99%
“…By reducing FOXO1 nuclear localization, GnRH could thus enhance the transactivation capacity of SF1, β-catenin, and Egr1. The ability of FOXO1 to inhibit Wnt/β-catenin signaling has recently been reported in osteoblast precursors as well as in sarcoma cell lines [58, 59], which supports this hypothesis. The underlying molecular mechanisms of this phenomenon are still to be determined.…”
Section: Discussionsupporting
confidence: 62%
“…45, 46, 47 Thus, FoxO1 may regulate osteogenic differentiation by competing with the TCF/LEF complex for β -catenin and inhibiting the canonical Wnt pathway. Our results are in support of our hypothesis.…”
Section: Discussionmentioning
confidence: 99%